Immunarray vs Sight Diagnostics
Immunarray vs Sight Diagnostics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunarray is on 39/100 and Sight Diagnostics on 63/100.
Where each one leads
Immunarray
Leads on none of the measures we hold for both companies.
Sight Diagnostics
- our overall score: 63/100 against 39/100
- agent readiness: 47/100 against 28/100
- domain rating: 43/100 against 18/100
- funding raised: $124M against $10.0M
At a glance
| Measure | Immunarray | Sight Diagnostics |
|---|---|---|
| What it is | ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform. | Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer. |
| Category | Healthcare, Blood, Diagnostics, Immunology | Healthcare, Diagnostics, Blood, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2006 | 2011 |
| Headquarters | Richmond, United States | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Immunarray | Sight Diagnostics |
|---|---|---|
| Employees | Not published | 65 |
| Headcount growthLast 12 months | Not published | -29.4% |
| Total funding | $10.0M | $124M |
| Latest round | Series A | Series D |
| Valuation | Not published | $500M |
| LinkedIn followers | Not published | 16,273 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunarray | Sight Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 63/100 |
| Traction | 35/100 | 58/100 |
| Team | 30/100 | 70/100 |
| Community | 13/100 | 8/100 |
| Search visibility | 5/100 | 32/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (28/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 18/100 | 43/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunarray | Sight Diagnostics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Wix |
What users say
| Measure | Immunarray | Sight Diagnostics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 0 positive, 2 negative across 2 threads |
“Sight Diagnostics on brink of closure after laying off all employees.”r/Layoffs
Immunarray vs Sight Diagnostics: common questions
Which is better, Immunarray or Sight Diagnostics?
On our 0-100 score Sight Diagnostics rates higher (63/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Immunarray and Sight Diagnostics compare on the numbers?
Sight Diagnostics leads on our overall score (63/100 against 39/100), agent readiness (47/100 against 28/100), domain rating (43/100 against 18/100), funding raised ($124M against $10.0M).
What do real users say about Immunarray and Sight Diagnostics?
Sight Diagnostics: 0 positive and 2 negative mentions across 2 Reddit threads we track, mostly in r/Layoffs.
Read the full Immunarray review and pricing or the Sight Diagnostics review and pricing. You can also browse other Immunarray alternatives we track.